Page 174 - 79_01

J.
R.
Lacadena
y
F.
Mayor
Menéndez

7. Kobel,
H.R.;
Brun,
R.B.;
Fischberg,
M.
Nuclear
transplantation
with
melanophores,
ciliated

epidermal
cells,
and
the
established
cell
line
A-­-8
in
Xenopus
laevis.
J.
Embryol.
Exp.

Morphol.
29,
539-­-547
(1973).

8. Di
Berardino,
M.A.;
Hoffner,
N.J.
The
current
status
of
cloning
and
nuclear
reprogramming

in
amphibian
eggs.
En
Differentiation
and
Neoplasia
(Results
and
Problems
in
Cell

Differentiation,
vol.
11);
(edited
by
McKinell,
R.G.;
Di
Berardino,
M.A.;
Blumenfeld,
M.;

Bergard,
R.D.,
Eds.;
Springer
Verlag;
Berlin,
1980;
p
53-­-64.

9. Frisén,
J.;
Lendahl,
U.;
Perimann,
T.
Mature
cells
can
be
reprogrammed
to
become

pluripotent.
The
2012
Nobel
Prize
in
Physiology
or
Medicine
–
Advanced
Information.

http://Nobelprize.org
(2012)

10. Waddington,
C.H.
The
strategy
of
the
genes;
a
discussion
of
some
aspects
of
theoretical

biology;
Allen
&
Unwin;
Londres,
1957.

11. McGrath,
J.;
Solter,
D.
Inability
of
mouse
blastomere
nuclei
transferred
to
enucleated

zygotes
to
support
development
in
vitro.
Science
226,
1317-­-1318
(1984).

12. Wilmut,
I.;
Schnieke,
A.E.;
McWhir,
J.;
Kind,
A.J.;
Campbell,
K.H.S.
Viable
offspring
derived

from
fetal
and
adult
mammalian
cells.
Nature
385,
810-­-813
(1997).

13. Lacadena,
J.R.
Genética
y
Sociedad.
Real
Acad.
Nac.
Farmacia;
Madrid,
2011;
p.
147.
(El

contenido
de
este
apartado
está
necesariamente
basado,
aunque
debidamente

actualizado,
en
el
texto
publicado
dentro
del
Discurso
leído
por
el
autor
en
la
Sesión

Inaugural
del
Curso
de
la
Real
Academia
Nacional
de
Farmacia
celebrada
el
13
de
enero

de
2011).

14. Ver
revisiones
por
Hochedlinger,
K.;
Plath,
K.
Epigenetic
reprogramming
and
induced

pluripotency.
Development
136,
509-­-523
(2009).
Izpisúa
Belmonte,
J.C.;
Ellis,
J.;

Hochedlinger,
K.;
Yamanaka,
S.
Induced
pluripotent
stem
cells
and
reprogramming:
seeing

the
science
through
the
hype.
Nature
Reviews
Genetics
10,
878-­-883
(2009).
Hochedlinger,

K.
El
poder
terapéutico
de
nuestras
células.
Investigación
y
Ciencia
(julio
2010),
24-­-31

(2010).

15. Takahashi,
K.;
Mitsui,
K.;
Yamanaka,
S.
Role
of
Eras
in
promoting
tumour-­-like
properties
in

mouse
embryonic
stem
cells.
Nature
423,
541-­-545
(2003).

16. Mitsui,
K.;
Tokuzawa,
Y.;
Itoh,
H.;
Segawa,
K.;
Murakami,
M.;
Takahashi,
K.
et
al.
The

homeoprotein
Nanog
is
required
for
maintenance
of
pluripotency
in
mouse
epiblast
and

ES
cells.
Cell
113,
631-­-642
(2003).

17. Chambers,
I.;
Colby,
D.;
Robertson,
M.;
Nichols,
J.;
Lee,
S.;
Tweedie,
S.
et
al.
Functional

expression
cloning
of
Nanog,
a
pluripotency
sustaining
factor
in
embryonic
stem
cells.
Cell

113,
643-­-655
(2003).

18. Tada,
M.;
Takahama,
Y.;
Abe,
K.;
Nakatsuji,
N.;
Tada,
T.
Nuclear
reprogramming
of
somatic

cells
by
in
vitro
hybridization
with
ES
cells.
Curr.
Biol.
11,
1553-­-1558
(2001).

19. Takahashi,
K.;
Yamanaka,
S.
Induction
of
pluripotent
stem
cells
from
mouse
embryonic

and
adult
fibroblast
cultures
by
defined
factors.
Cell
126,
663-­-676
(2006).

20. Yamanaka,
S.
Strategies
and
new
developments
in
the
generation
of
patient-­-specific

pluripotent
stem
cells.
Cell
Stem
Cell
1,
39-­-49
(2007).

21. Maherali,
N.;
Sridharan,
R.;
Xie,
W.;
Utikal,
J.;
Eminli,
S.;
Arnold,
K.;
Stadtfeld,
M.;
Yachenko,

R.;
Hieu,
J.
TC.;
Jaenisch,
R.;
Plath,
K.;
Hochedlinger,
K.
Directly
reprogrammed
fibroblasts

show
global
epigenetic
remodelling
and
widespread
tissue
contribution.
Cell
Stem
Cell
1,

55-­-70
(2007).
Wernig,
M.;
Meissner,
A.;
Foreman,
R.;
Brambrink,
T.;
Ku,
M.;
Hochedlinger,

K.;
Bernstein,
B.E.;
Jaenisch,
R.
In
vitro
reprogramming
of
fibroblasts
into
a
pluripotent
ES-­-
cell-­-like
state.
Nature
448,
318-­-324
(2007).

22. Okita,
K.;
Ichisaka,
T.;
Yamanaka,
S.
Generation
of
germline-­-competent
induced

pluripotent
stem
cells.
Nature
448,
313-­-317
(2007).

168